CITRATE ANTICOAGULATION AND DIVALENT-CATIONS IN HEMODIALYSIS

被引:20
作者
JANSSEN, MJFM
HUIJGENS, PC
BOUMAN, AA
OE, PL
VANDERMEULEN, J
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT HEMATOL,1081 HV AMSTERDAM,NETHERLANDS
[2] FREE UNIV AMSTERDAM HOSP,DEPT CLIN CHEM,1081 HV AMSTERDAM,NETHERLANDS
关键词
CITRATE ANTICOAGULATION; CALCIUM; MAGNESIUM; ACTIVATED PARTIAL THROMBOPLASTIN TIME; LEE-WHITE WHOLE BLOOD CLOTTING TIME; ACTIVATED CLOTTING TIME;
D O I
10.1159/000170179
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anticoagulation with citrate in combination with a calcium-free, magnesium-containing dialysate (Ca-Mg+) and intravenous supplementation of calcium is a safe procedure in renal failure patients at high risk of bleeding. Since magnesium may antagonize the anticoagulant effect of citrate by forming complexes with citrate, we studied the in vitro and in vivo interactions of calcium and magnesium on citrate anticoagulation. In the in vitro studies the activated partial thromboplastin time (APTT) was 88 s, both after addition of 3.0 mu mol magnesium and after addition of 1.0 mu mol calcium. The combination of 2.4 mu mol magnesium and 1.0 mu mol calcium achieved similar APTT values of about 35 s as 3.5 mu mol calcium alone. Moreover, in a Lee-White blood clotting time, the anticoagulant effect of 7 mu mol citrate was neutralized by either 10.5 mu mol of a mixture of the two cations or 10.5 mu mol calcium chloride alone. In 6 chronic hemodialysis patients the in vivo interactions of calcium and magnesium on citrate were measured. At the dialyzer outlet, the whole blood activated clotting time (ACT) was significantly (p < 0.05) shorter during dialysis with a Ca-Mg+ dialysate than during dialysis with a calcium- and magnesium-free dialysate (Ca-Mg-). With the Ca-Mg- dialysate the ACT at the dialyzer outlet was still significantly longer than the ACT in the arterial line before citrate infusion. We also compared the serum concentrations of calcium and magnesium during the Ca-Mg- dialysate which was used in combination with intravenous calcium and magnesium supplementation - 0.18 and 0.08 mmol/min respectively - and during a conventional calcium- and magnesium-containing dialysate (Ca+Mg+). Serum total calcium concentrations were significantly higher during and after the Ca+Mg+ dialysate than with the Ca-Mg- dialysate. Plasma-ionized calcium concentrations were similar for the two dialysates at all times. However, the differences between post- and predialysis (post- minus predialysis) ionized calcium and serum magnesium with the Ca+Mg+ dialysate were significantly (p < 0.05) higher than with the Ca-Mg- dialysate. Thus, citrate achieves a more pronounced anticoagulation of the extracorporeal system with a Ca-Mg- dialysate than with a Ca-Mg+ dialysate. However, the calcium and magnesium supplementation rates - 0.18 and 0.08 mmol/min respectively result in a short-term decrease of these divalent cations which may have repercussions for the parathyroid gland function.
引用
收藏
页码:308 / 316
页数:9
相关论文
共 20 条
[1]  
Morita Y., Johnson R.W., Dorn R.E., Hall D.S., Regional anticoagulation during hemodialysis using citrate, Am J Med Sci, 242, pp. 32-42, (1961)
[2]  
Pinnick R.V., Wiegman T.B., Diederich D.A., Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding, N Engl J Med, 308, pp. 258-261, (1983)
[3]  
Faber L.M., Dc Vries P.M.J.M., Oc P.L., Van der Meulen J., Donker A.J.M., Citrate hemodialysis, Neth J Med, 37, pp. 219-224, (1990)
[4]  
Van der Meulen J., Janssen M.J.F.M., Langendijk P.N.J., Bouman A.A., Oe P.L., Citrate anticoagulation and dialysatc with reduced buffer content in chronic hemodialysis, Clin Nephrol, 37, pp. 36-41, (1992)
[5]  
Janssen M.J.F.M., Huijgens P.C., Bouman A.A., Oe P.L., Donker A.J.M., Van der Meulen J., Citrate versus heparin anticoagulation in chronic hemodialvsis patients, Nephrol Dial Transplant, 8, pp. 1228-1233, (1993)
[6]  
Von Brecht J.H., Flanigan M.J., Freeman R.M., Lim V.S., Regional anticoagulation: Hemodialysis with hypertonic trisodium citrate, Am J Kidney Dis, 8, pp. 196-201, (1986)
[7]  
Kelieher S.P., Schulman G., Severe metabolic alkalosis complicating regional citrate hemodialysis, Am J Kidney Dis, 9, pp. 235-236, (1987)
[8]  
Silverstein F.J., Oster J.R., Perez G.O., Materson B.J., Lopez R.A., Al-Reshaid K., Metabolic alkalosis induced by regional citrate dialysis, ASAIO Trans, 35, pp. 22-25, (1989)
[9]  
Chamey D.I., Salmond R., Cardiac arrest after hypertonic citrate anticoagulation for chronic hemodialysis, ASAIO Trans, 36, pp. 217-219, (1990)
[10]  
Wiegmann T.B., McDougall M.L., Diederich D.A., Long-term comparisons of citrate and heparin asanticoagulants for hemodialysis, Am J Kidney Dis, 9, pp. 430-435, (1987)